Panel Discussion: Utilizing Discovery Platforms to Hunt for the Perfect Target & Advance T-Cell Engager Efficacy in Solid & Liquid Tumors
- Discussing the methodologies currently used to identify antigens in multiple myeloma and B-cell lymphoma
- Debating whether therapeutic failure in hematologic cancers stems from T-cell exhaustion or from a lack of high-density, specific antigens to target
- Identifying shared antigens vs personalized neoantigens in solid tumor populations